Jerry Avorn

From WikiMD's Food, Medicine & Wellness Encyclopedia

Jerry Avorn is a prominent American physician, epidemiologist, and writer. He is best known for his work in the field of pharmacology, particularly in the area of drug safety and health policy. Avorn is a Professor of Medicine at Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women's Hospital.

Early life and education[edit | edit source]

Jerry Avorn was born in New York City. He completed his undergraduate studies at Columbia University, where he majored in English literature. He then went on to earn his medical degree from Harvard Medical School.

Career[edit | edit source]

After completing his medical degree, Avorn completed his residency in internal medicine at Beth Israel Hospital in Boston. He then joined the faculty of Harvard Medical School, where he has remained for the duration of his career.

Avorn's research focuses on the use of prescription drugs by older adults, and the impact of pharmaceutical industry marketing practices on prescribing behavior. He is the author of the book Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs, which explores these topics in depth.

In addition to his research, Avorn is also a recognized leader in the field of health policy. He has testified before Congress on numerous occasions, and his work has been influential in shaping policy related to drug safety and efficacy.

Recognition[edit | edit source]

Avorn's work has been recognized with numerous awards and honors. He is a member of the Institute of Medicine of the National Academy of Sciences, and a Fellow of the American Association for the Advancement of Science.

See also[edit | edit source]

References[edit | edit source]


External links[edit | edit source]

‎ ‎


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Admin, Prab R. Tumpati, MD